Sonic Healthcare Limited (ASX:SHL) Directors Insider Transactions
The Directors and Chief Executives of Sonic Healthcare Limited (ASX:SHL) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Sonic Healthcare Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Sonic Healthcare Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Sonic Healthcare Limited Directors/Insider Transactions Activity
List of Insider trades activity from Sonic Healthcare Limited (SHL).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 16 Oct 2025 | Evans (Nicola Wakefield) | Director (Non-Executive) | 2,500 | 35,305 | Purchase at price 14.12 per share. |
| 15 Oct 2025 | Giles (Katharine M.D.) | Independent Non-Executive Director | 1,000 | 13,781 | Purchase at price 13.78 per share. |
| 03 Oct 2025 | Giles (Katharine M.D.) | Independent Non-Executive Director | 1,000 | 14,337 | Purchase at price 14.34 per share. |
| 02 Oct 2025 | Compton (Mark Raymond) | Chairman of the Board | 1,500 | 21,338 | Purchase at price 14.23 per share. |
| 01 Oct 2025 | Bennett (Christine) | Independent Non-Executive Director | 1,100 | 15,644 | Purchase at price 14.22 per share. |
| 29 Sep 2025 | Goldschmidt (Colin Stephen) | Chief Executive Officer | 10,217 | - | - |
| 29 Sep 2025 | Wilks (Christopher David) | Director (Executive) | 5,863 | - | - |
| 26 Sep 2025 | Spargo (Kathryn Dianne) | Independent Non-Executive Director | 3,500 | 48,716 | Purchase at price 13.92 per share. |
| 26 Sep 2025 | Crowe (Suzanne) | Independent Non-Executive Director | 2,365 | 32,696 | Purchase at price 13.83 per share. |
| 02 Sep 2025 | Goldschmidt (Colin Stephen) | Chief Executive Officer | 9,852 | - | - |
| 02 Sep 2025 | Wilks (Christopher David) | Director (Executive) | 3,754 | - | - |
| 09 Apr 2025 | Bennett (Christine) | Independent Non-Executive Director | 1,000 | 15,377 | Purchase at price 15.38 per share. |
| 08 Apr 2025 | Giles (Katharine M.D.) | Independent Non-Executive Director | 850 | 12,510 | Purchase at price 14.72 per share. |
| 25 Mar 2025 | Evans (Nicola Wakefield) | Director (Non-Executive) | 2,000 | 32,261 | Purchase at price 16.13 per share. |
| 10 Feb 2025 | Evans (Nicola Wakefield) | Director | 2,000 | - | - |
| 11 Dec 2024 | Bennett (Christine) | Independent Non-Executive Director | 1,000 | 18,138 | Purchase at price 18.14 per share. |
| 10 Dec 2024 | Compton (Mark Raymond) | Chairman of the Board | 1,000 | 18,143 | Purchase at price 18.14 per share. |
| 10 Dec 2024 | Spargo (Kathryn Dianne) | Independent Non-Executive Director | 1,500 | 27,262 | Purchase at price 18.18 per share. |
| 09 Dec 2024 | Crowe (Suzanne) | Independent Non-Executive Director | 348 | 6,431 | Purchase at price 18.48 per share. |
| 06 Nov 2024 | Giles (Katharine M.D.) | Independent Non-Executive Director | 250 | 4,743 | Purchase at price 18.97 per share. |
| 25 Sep 2024 | Goldschmidt (Colin Stephen) | Chief Executive Officer | 41,663 | - | - |
| 25 Sep 2024 | Wilks (Christopher David) | Director (Executive) | 21,711 | - | - |
| 29 May 2024 | Bennett (Christine) | Independent Non-Executive Director | 1,000 | 15,873 | Purchase at price 15.87 per share. |
| 23 May 2024 | Compton (Mark Raymond) | Chairman of the Board | 1,000 | 16,746 | Purchase at price 16.75 per share. |
| 23 May 2024 | Crowe (Suzanne) | Independent Non-Executive Director | 2,000 | 33,452 | Purchase at price 16.73 per share. |
| 22 May 2024 | Giles (Katharine M.D.) | Independent Non-Executive Director | 500 | 8,178 | Purchase at price 16.36 per share. |